1. MedMira (TSXV:MIR) Market cap: C$154.72 million; current share price: C$0.23; yearly gain: 840 percent Biotech company MedMira is responsible for the development of its Rapid Vertical Flow (RVF) Technology. Rapid-test applications built on RVF Technology provide hospitals, labs, clinics and patients with instant diagnoses for diseases including HIV and hepatitis C. On the final day of
...more